Filed: 5/14/2026ACC: 0001420506-26-001011
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 73 equity positions with a total reported market value of $979.81M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
73
Positions
$979.81M
Total AUM (reported)
50.42M
Total Shares
Allocation by class
COM$645.53M65.9%
PUT$105.38M10.8%
COM NEW$62.26M6.4%
SPONSORED ADS$54.67M5.6%
SPONSORED ADR$28.51M2.9%
CALL$25.79M2.6%
SHS$16.28M1.7%
Portfolio Concentration
Top 3$218.23M22.3%
4–10$272.69M27.8%
11–25$291.15M29.7%
Rest$197.75M20.2%
Top 3 weight
22.3%
Top 10 weight
50.1%
Voting Authority Distribution
Total shares with voting rights: 50.42M
Sole
Full voting authority
50.42M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole73
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings73
Rows:
SPDR SERIES TRUST
SOLEShares825K
TypeSH
Market value$105.38M
10.75%
Sole
825K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares2.88M
TypeSH
Market value$57.90M
5.91%
Sole
2.88M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares654.75K
TypeSH
Market value$54.95M
5.61%
Sole
654.75K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.31M
TypeSH
Market value$50.58M
5.16%
Sole
1.31M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares357.90K
TypeSH
Market value$40.85M
4.17%
Sole
357.90K
Shared
0.00
None
0.00
IMMUNOME INC
SOLEShares1.85M
TypeSH
Market value$40.47M
4.13%
Sole
1.85M
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares991.93K
TypeSH
Market value$37.81M
3.86%
Sole
991.93K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares354.91K
TypeSH
Market value$36.36M
3.71%
Sole
354.91K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares302.53K
TypeSH
Market value$33.69M
3.44%
Sole
302.53K
Shared
0.00
None
0.00
MONTE ROSA THERAPEUTICS INC
SOLEShares2M
TypeSH
Market value$32.93M
3.36%
Sole
2M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares1.85M
TypeSH
Market value$29.96M
3.06%
Sole
1.85M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares124.66K
TypeSH
Market value$28.51M
2.91%
Sole
124.66K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.50M
TypeSH
Market value$27.02M
2.76%
Sole
1.50M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares306K
TypeSH
Market value$26.61M
2.72%
Sole
306K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares71.55K
TypeSH
Market value$23.05M
2.35%
Sole
71.55K
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares1.14M
TypeSH
Market value$22.21M
2.27%
Sole
1.14M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares888.99K
TypeSH
Market value$20.77M
2.12%
Sole
888.99K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares466.35K
TypeSH
Market value$18.52M
1.89%
Sole
466.35K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares339.61K
TypeSH
Market value$16.70M
1.70%
Sole
339.61K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares460.31K
TypeSH
Market value$16.28M
1.66%
Sole
460.31K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares1.10M
TypeSH
Market value$13.94M
1.42%
Sole
1.10M
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares196.03K
TypeSH
Market value$12.53M
1.28%
Sole
196.03K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP III
SOLEShares1.21M
TypeSH
Market value$12.28M
1.25%
Sole
1.21M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares197.76K
TypeSH
Market value$11.50M
1.17%
Sole
197.76K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares166.35K
TypeSH
Market value$11.26M
1.15%
Sole
166.35K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SERIES TRUSTSOLE | PUT | 825K | SH | $105.38M 10.75% | 825K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 2.88M | SH | $57.90M 5.91% | 2.88M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 654.75K | SH | $54.95M 5.61% | 654.75K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.31M | SH | $50.58M 5.16% | 1.31M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 357.90K | SH | $40.85M 4.17% | 357.90K | 0.00 | 0.00 |
IMMUNOME INCSOLE | COM | 1.85M | SH | $40.47M 4.13% | 1.85M | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 991.93K | SH | $37.81M 3.86% | 991.93K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 354.91K | SH | $36.36M 3.71% | 354.91K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 302.53K | SH | $33.69M 3.44% | 302.53K | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCSOLE | COM | 2M | SH | $32.93M 3.36% | 2M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 1.85M | SH | $29.96M 3.06% | 1.85M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 124.66K | SH | $28.51M 2.91% | 124.66K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.50M | SH | $27.02M 2.76% | 1.50M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 306K | SH | $26.61M 2.72% | 306K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 71.55K | SH | $23.05M 2.35% | 71.55K | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 1.14M | SH | $22.21M 2.27% | 1.14M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 888.99K | SH | $20.77M 2.12% | 888.99K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 466.35K | SH | $18.52M 1.89% | 466.35K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 339.61K | SH | $16.70M 1.70% | 339.61K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 460.31K | SH | $16.28M 1.66% | 460.31K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 1.10M | SH | $13.94M 1.42% | 1.10M | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 196.03K | SH | $12.53M 1.28% | 196.03K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIISOLE | USD CL A ORD SHS | 1.21M | SH | $12.28M 1.25% | 1.21M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 197.76K | SH | $11.50M 1.17% | 197.76K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 166.35K | SH | $11.26M 1.15% | 166.35K | 0.00 | 0.00 |
Page 1 of 3